Susquehanna International Group, LLP Roivant Sciences Ltd. Transaction History

Susquehanna International Group, LLP

$823 Billion
Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 458,589 shares of ROIV stock, worth $9.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

458,589

Previous 133,707 242.98%

Holding current value

$9.3 Million

Previous $1.51 Million 360.69%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$10.74 - $15.28 $3.49 Million - $4.96 Million	324,882 Added 242.98%	458,589 $6.94 Million
Q2 2025 Aug 14, 2025	SELL	$9.08 - $11.62 $1.16 Million - $1.48 Million	-127,351 Reduced 48.78%	133,707 $1.51 Million
Q1 2025 May 14, 2025	BUY	$10.09 - $12.08 $1.35 Million - $1.62 Million	134,271 Added 105.9%	261,058 $2.63 Million
Q4 2024 Feb 14, 2025	SELL	$11.16 - $12.71 $2.04 Million - $2.33 Million	-183,220 Reduced 59.1%	126,787 $1.5 Million
Q3 2024 Nov 14, 2024	BUY	$10.17 - $12.5 $158,468 - $194,775	15,582 Added 5.29%	310,007 $3.58 Million

Q2 2024 Aug 15, 2024	SELL	$10.36 - $11.74 $3.21 Million - $3.64 Million	-309,637 Reduced 51.26%	294,425 $3.11 Million
Q1 2024 May 07, 2024	BUY	$9.87 - $11.8 $5.96 Million - $7.13 Million	604,062 New	604,062 $6.37 Million
Q3 2023 Nov 14, 2023	BUY	$9.76 - $13.19 $1.5 Million - $2.03 Million	154,035 Added 307.94%	204,056 $2.38 Million
Q2 2023 Aug 11, 2023	SELL	$7.09 - $10.08 $1.21 Million - $1.73 Million	-171,346 Reduced 77.4%	50,021 $504,000
Q1 2023 May 16, 2023	BUY	$6.92 - $9.98 $1.34 Million - $1.93 Million	192,946 Added 678.89%	221,367 $1.63 Million
Q4 2022 Feb 14, 2023	SELL	$3.36 - $7.99 $47,013 - $111,796	-13,992 Reduced 32.99%	28,421 $227,000
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $3,120 - $29,611	6,118 Added 16.86%	42,413 $137,000
Q2 2022 Aug 15, 2022	SELL	$2.81 - $4.84 $483 - $832	-172 Reduced 0.47%	36,295 $148,000
Q1 2022 May 16, 2022	BUY	$4.74 - $9.91 $121,931 - $254,924	25,724 Added 239.45%	36,467 $180,000
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $62,953 - $145,245	10,743 New	10,743 $108,000

Others Institutions Holding ROIV

# of Institutions

374

Shares Held

436M

Call Options Held

6.03M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $14.3B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Roivant Sciences Ltd. Transaction History